Sequential Versus Combination Chemotherapy in Advanced Colorectal Carcinoma

NCT00312000 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

820

Enrollment

OTHER

Sponsor class

Conditions

Advanced Colorectal Cancer

Interventions

DRUG: capecitabine-irinotecan
DRUG: capecitabine+irinotecan (1st line)

Sponsor

Dutch Colorectal Cancer Group

Collaborators

[object Object]
[object Object]
[object Object]